|
Bone Health symposium (for health care professionals)
There is still time to register for this unique CME-certified case-based symposium focused on the important clinical considerations associated with bone health in breast cancer patients, including the most recent data on bisphosphonates and mechanisms of RANKL inhibition.
<HR class=style1> DATE, TIME, AND LOCATION <TABLE width=430><TBODY><TR><TD width=293>Friday, December 11, 2009 </TD><TD width=2></TD><TD width=135>8:00 PM - 10:30 PM </TD></TR><TR><TD width=430 colSpan=3></TD></TR><TR><TD width=293>Registration and Dinner</TD><TD width=2></TD><TD width=135>8:00 PM - 8:30 PM </TD></TR><TR><TD width=295>Symposium</TD><TD width=2></TD><TD width=135>8:30 PM - 10:30 PM </TD></TR></TBODY></TABLE>San Antonio Marriott Rivercenter Hotel <HR class=style1>Salons CDE 101 Bowie Street San Antonio, Texas AGENDA Welcome and Introduction Gregory R. Mundy, MD Program Director Traditional Approaches for Managing Bone Health in Breast Cancer: Bisphosphonates Michael Gnant, MD Targeting Osteoclast Inhibition: Mechanisms, Rationale, and Data Allan Lipton, MD Applying What We Know to Our Patients: Practical Case Presentations Adam M. Brufsky, MD, PhD Question and Answer Session Register for this satellite symposium online at: http://clinicaloptions.com/Oncology/Live%20Events/Satellite%20Symposium/Bone%20Health.aspx |
| All times are GMT -7. The time now is 05:26 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021